Matthew Wein

Companies

• Metagenomi Therapeutics, Inc.Officer Feb 8, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMetagenomi Therapeutics, Inc. MGX126,133 shares²$102.8K at $0.81Sep 8, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 8, 2026Sold 358 shares at $1.16 of Metagenomi Therapeutics, Inc.²
• Jun 5, 2026Sold 558 shares at $1.30 of Metagenomi Therapeutics, Inc.³
• Apr 1, 2026Granted 11,000 shares of Metagenomi Therapeutics, Inc.⁴
• Mar 5, 2026Sold 482 shares at $1.60 of Metagenomi Therapeutics, Inc.⁵
• Dec 5, 2025Sold 199 shares at $1.77 of Metagenomi Therapeutics, Inc.⁶
• Dec 1, 2025Granted 96,000 shares at $1.60 of Metagenomi Therapeutics, Inc.⁷
• Sep 5, 2025Sold 199 shares at $1.81 of Metagenomi Therapeutics, Inc.⁷
• Jun 6, 2025Sold 199 shares at $1.75 of Metagenomi Therapeutics, Inc.⁸
• Apr 1, 2025Granted 3,775 shares of Metagenomi Therapeutics, Inc.⁹
• Apr 1, 2025Granted 3,650 shares of Metagenomi Therapeutics, Inc.⁹
• Mar 5, 2025Sold 930 shares at $1.87 of Metagenomi Therapeutics, Inc.¹⁰
• Apr 1, 2024Granted 10,397 shares of Metagenomi Therapeutics, Inc.¹¹